Top 5 Clinical Trials Shaping Medicine in 2025
From precision oncology to gene editing, these standout trials could redefine how to diagnose and treat rare diseases and cancer
Inside the Diagnostics Industry-dtet
Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge
The pandemic may have set the stage for a jump in infections from these four nemeses
Lab Data’s New Role as the Backbone of AI-Driven Clinical Trials
Learn how research and development labs can leverage AI to transform laboratory data into actionable insights
New ACOG Guidelines Recommend cfDNA-Based NIPT for All Pregnancies, Not Just Risky Ones
...
Already a member? Log in here
Inside the Diagnostics Industry: New Government BRCA Test Guidelines Are a Mixed Bag for Genetic Testing Labs
From - Diagnostic Testing & Emerging Technologies
The US Preventive Services Task Force (USPSTF) issued updated recommendations for BRCA-related cancer risk assessment…
Government Report Casts Doubt on Cost-Effectiveness of Leading Genetic Colorectal Cancer Screening Test
...
Already a member? Log in here
Search Intensifies for Markers for Prosthetic Joint Infection
...
Already a member? Log in here
Partnerships, IT Solutions Improve Infectious Disease Diagnostic Stewardship
From - Diagnostic Testing & Emerging Technologies
Appropriate use of testing is becoming a greater challenge, given the growing number of available diagnostic tests and their increasing complexity&…
The Practice of Early Gestational Diabetes Screening Evaluated
...
Already a member? Log in here
Exome Sequencing Improves Diagnosis of Fetal Structural Anomalies
From - Diagnostic Testing & Emerging Technologies
Prenatal diagnostics have evolved from conventional cytogenetic analysis to increasingly chromosomal microarray analysis, within the last…
Evidence Suggests Need for Expanded HCV Testing, Particularly Coupled With Opioid Screening in Young People
From - Diagnostic Testing & Emerging Technologies
Current hepatitis C virus (HCV) screening strategies may not be adequate in the face of the opioid epidemic…
PAMA Unlocks Golden Age for Innovative Diagnostics
By Chance Scott bio
The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition…
